Hamza Khan

Hamza Khan is an accomplished oncology clinical development professional with extensive experience in the pharmaceutical industry. Currently serving as the Oncology Clinical Development Associate Director at GSK since March 2023, Hamza previously held various roles at Merck from September 2018 to March 2023, including Senior Clinical Scientist and Senior Oncology Clinical Site Manager. Prior experience includes serving as an Oncology Clinical Research Associate at Scimega and as a Clinical Trial Monitor at the Canadian Cancer Trials Group. Hamza holds a Master’s Degree in Neuroscience and a Bachelor of Science (Honors) in Life Sciences, both from Queen's University.